INCYTE CORPORATION Current Liabilities
INCYTE CORPORATION (INCY) had Current Liabilities of $1.49 billion as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-04-28
- 2026-03-31: Liabilities, Current $1.49B.
- 2025-12-31: Liabilities, Current $1.52B.
- 2025-09-30: Liabilities, Current $1.34B.
- 2025-06-30: Liabilities, Current $1.28B.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.49B 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $1.52B 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $1.34B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.28B 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $1.72B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.64B 10-K · filed 2026-02-10 | |
| 2024-09-30 | $1.50B 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $1.34B 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $1.40B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $1.24B 10-K · filed 2025-02-10 | |
| 2023-09-30 | $1.12B 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $1.12B 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $1.01B 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $1.16B 10-K · filed 2024-02-13 | |
| 2022-09-30 | $1.01B 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $926.67M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $886.16M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $854.31M 10-K · filed 2023-02-07 | |
| 2021-09-30 | $742.71M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $660.32M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $623.88M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $631.20M 10-K · filed 2022-02-08 | |
| 2020-09-30 | $606.20M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $556.51M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $503.41M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $513.34M 10-K · filed 2021-02-09 | |
| 2019-09-30 | $461.68M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $367.11M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $364.51M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $425.28M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $422.49M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $368.24M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $381.07M 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $375.40M 10-K · filed 2019-02-14 | |
| 2017-09-30 | $319.94M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $293.16M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $304.72M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $273.50M 10-K · filed 2018-02-15 | |
| 2016-09-30 | $240.54M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $198.99M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $200.32M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $168.01M 10-K · filed 2017-02-14 | |
| 2015-09-30 | $155.82M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $192.47M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $225.59M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $221.06M 10-K · filed 2016-02-12 | $221.51M 10-K · filed 2015-02-17 |
| 2014-09-30 | $124.66M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $112.55M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $106.94M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $108.04M 10-K · filed 2015-02-17 | |
| 2013-09-30 | $109.50M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $102.96M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $121.28M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $136.07M 10-K · filed 2014-02-21 | |
| 2012-09-30 | $137.64M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $139.73M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $142.30M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $135.61M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $120.96M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $110.67M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $110.18M 10-Q · filed 2011-05-03 | |
| 2010-12-31 | $113.57M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |